Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Weidemann, F; Herrmann, S; Stork, S; Niemann, M; Frantz, S; Lange, V; Beer, M; Gattenlohner, S; Voelker, W; Ertl, G; Strotmann, JM.
Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis.
Circulation. 2009; 120(7):577-584 Doi: 10.1161/CIRCULATIONAHA.108.847772 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Co-authors Med Uni Graz: Beer Meinrad; Gattenlöhner Stefan
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: BACKGROUND: In this prospective follow-up study, the effect of myocardial fibrosis on myocardial performance in symptomatic severe aortic stenosis was investigated, and the impact of fibrosis on clinical outcome after aortic valve replacement (AVR) was estimated. METHODS AND RESULTS: Fifty-eight consecutive patients with isolated symptomatic severe aortic stenosis underwent extensive baseline characterization before AVR. Standard and tissue Doppler echocardiography and cardiac magnetic resonance imaging (late-enhancement imaging for replacement fibrosis) were performed at baseline and 9 months after AVR. Endomyocardial biopsies were obtained intraoperatively to determine the degree of myocardial fibrosis. Patients were analyzed according to the severity of interstitial fibrosis in cardiac biopsies (severe, n=21; mild, n=15; none, n=22). The extent of histologically determined cardiac fibrosis at baseline correlated closely with New York Heart Association functional class and markers of longitudinal systolic function (all P<0.001) but not global ejection fraction or aortic valve area. Nine months after AVR, the degree of late enhancement remained unchanged, implying that AVR failed to reduce the degree of replacement fibrosis. Patients with no fibrosis experienced a marked improvement in New York Heart Association class from 2.8+/-0.4 to 1.4+/-0.5 (P<0.001). Only parameters of longitudinal systolic function predicted this functional improvement. Four patients with severe fibrosis died during follow-up, but no patient from the other groups died. CONCLUSIONS: Myocardial fibrosis is an important morphological substrate of postoperative clinical outcome in patients with severe aortic stenosis and was not reversible after AVR over the 9 months of follow-up examined in this study. Because markers of longitudinal systolic function appear to indicate sensitively both the severity of myocardial fibrosis and the clinical outcome, they may prove valuable for preoperative risk assessment in patients with aortic stenosis.
Find related publications in this database (using NLM MeSH Indexing): Aged -; Aortic Valve - pathology Aortic Valve - surgery; Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - physiopathology Aortic Valve Stenosis - surgery; Biopsy -; Endomyocardial Fibrosis - complications Endomyocardial Fibrosis - physiopathology; Female -; Fibrosis -; Follow-Up Studies -; Heart Valve Prosthesis -; Heart Ventricles - pathology Heart Ventricles - physiopathology; Humans -; Magnetic Resonance Imaging -; Male -; Middle Aged -; Myocardium - pathology; Predictive Value of Tests -; Prognosis -; Prospective Studies -; Treatment Outcome -
Find related publications in this database (Keywords): fibrosis; imaging; myocardium; outcome studies; stenosis; valves